Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study.

Lucidi P, Porcellati F, Candeloro P, Cioli P, Andreoli AM, Marzotti S, Schmidt R, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):709-16. doi: 10.1016/j.numecd.2014.02.008. Epub 2014 Feb 22.

PMID:
24702815
[PubMed - in process]
2.

Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.

Porcellati F, Lucidi P, Bolli GB, Fanelli CG.

Diabetes Care. 2013 Dec;36(12):3860-2. doi: 10.2337/dc13-2088. No abstract available.

PMID:
24265365
[PubMed - in process]
3.

Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.

Baldi S, Bonnet F, Laville M, Morgantini C, Monti L, Hojlund K, Ferrannini E, Natali A; RISC Investigators.

Diabetes Care. 2013 Dec;36(12):4125-31. doi: 10.2337/dc13-0682. Epub 2013 Oct 15.

PMID:
24130363
[PubMed - in process]
4.

Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.

Kozakova M, Natali A, Dekker J, Beck-Nielsen H, Laakso M, Nilsson P, Balkau B, Ferrannini E; RISC Investigators.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1409-17. doi: 10.1161/ATVBAHA.112.300948. Epub 2013 Apr 18.

PMID:
23599442
[PubMed - indexed for MEDLINE]
Free Article
5.

Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes.

Lucidi P, Porcellati F, Rossetti P, Candeloro P, Andreoli AM, Cioli P, Hahn A, Schmidt R, Bolli GB, Fanelli CG.

Diabetes Care. 2012 Dec;35(12):2647-9. doi: 10.2337/dc12-0271. Epub 2012 Oct 18.

PMID:
23086139
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

From metabolic normality to cardiometabolic risk factors in subjects with obesity.

Bobbioni-Harsch E, Pataky Z, Makoundou V, Laville M, Disse E, Anderwald C, Konrad T, Golay A; RISC Investigators.

Obesity (Silver Spring). 2012 Oct;20(10):2063-9. doi: 10.1038/oby.2012.69. Epub 2012 Mar 16.

PMID:
22421925
[PubMed - indexed for MEDLINE]
7.

Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.

Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, Gastaldelli A, Ferrannini E; RISC Investigators.

Hepatology. 2012 May;55(5):1406-15. doi: 10.1002/hep.25555.

PMID:
22334565
[PubMed - indexed for MEDLINE]
8.

Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus.

Porcellati F, Lucidi P, Rossetti P, Candeloro P, Andreoli AM, Marzotti S, Cioli P, Bolli GB, Fanelli CG.

Diabetes Care. 2011 Dec;34(12):2521-3. doi: 10.2337/dc11-1064. Epub 2011 Oct 4.

PMID:
21972412
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.

Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H; RISC Investigators.

J Intern Med. 2012 Mar;271(3):294-304. doi: 10.1111/j.1365-2796.2011.02442.x. Epub 2011 Sep 14.

PMID:
21883535
[PubMed - indexed for MEDLINE]
10.

Pharmacokinetics and pharmacodynamics of basal insulins.

Porcellati F, Bolli GB, Fanelli CG.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S15-24. doi: 10.1089/dia.2011.0038. Review.

PMID:
21668333
[PubMed - indexed for MEDLINE]
11.

Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.

Rebelos E, Muscelli E, Natali A, Balkau B, Mingrone G, Piatti P, Konrad T, Mari A, Ferrannini E; RISC Study Investigators.

Diabetes. 2011 Jul;60(7):1938-45. doi: 10.2337/db11-0217. Epub 2011 May 26.

PMID:
21617179
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in type 2 diabetes.

Bolli GB, Lucidi P, Porcellati F, Fanelli CG.

Diabetes Care. 2011 May;34 Suppl 2:S220-4. doi: 10.2337/dc11-s224. No abstract available.

PMID:
21525459
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.

Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, Mari A, Balkau B; RISC Study Group.

Diabetes. 2011 Jun;60(6):1660-7. doi: 10.2337/db10-1806. Epub 2011 Apr 26.

PMID:
21521874
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

Lucidi P, Porcellati F, Rossetti P, Candeloro P, Cioli P, Marzotti S, Andreoli AM, Fede R, Bolli GB, Fanelli CG.

Diabetes Care. 2011 Jun;34(6):1312-4. doi: 10.2337/dc10-1911. Epub 2011 Apr 15.

PMID:
21498786
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study.

Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M, Beck-Nielsen H, Mari A; RISC Investigators.

Diabetologia. 2011 Jun;54(6):1507-16. doi: 10.1007/s00125-011-2112-x. Epub 2011 Mar 22.

PMID:
21424899
[PubMed - indexed for MEDLINE]
16.

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.

Bolli GB, Luzio S, Marzotti S, Porcellati F, Sert-Langeron C, Charbonnel B, Zair Y, Owens DR.

Diabetes Obes Metab. 2011 Mar;13(3):251-7. doi: 10.1111/j.1463-1326.2010.01343.x.

PMID:
21205115
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A novel surrogate index for hepatic insulin resistance.

Vangipurapu J, Stančáková A, Kuulasmaa T, Paananen J, Kuusisto J; EGIR-RISC Study Group, Ferrannini E, Laakso M.

Diabetologia. 2011 Mar;54(3):540-3. doi: 10.1007/s00125-010-1966-7. Epub 2010 Nov 25.

PMID:
21107521
[PubMed - indexed for MEDLINE]
18.

Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance.

Natali A, Muscelli E, Mari A, Balkau B, Walker M, Tura A, Anderwald C, Golay A, Ferrannini E; Relationship between Insulin Sensitivity and Cardiovascular disease investigators.

J Clin Endocrinol Metab. 2010 Oct;95(10):4703-11. doi: 10.1210/jc.2009-2721. Epub 2010 Jul 21.

PMID:
20660046
[PubMed - indexed for MEDLINE]
19.

Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults.

Anderwald C, Stadler M, Golay A, Krebs M, Petrie J, Luger A; RISC Investigators.

Heart. 2010 Aug;96(15):1191-200. doi: 10.1136/hrt.2009.177436.

PMID:
20639236
[PubMed - indexed for MEDLINE]
20.

Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population.

Kozàkovà M, Palombo C, Morizzo C, Nolan JJ, Konrad T, Balkau B; RISC Investigators.

Eur Heart J. 2010 Jun;31(12):1511-9. doi: 10.1093/eurheartj/ehq092. Epub 2010 Apr 17.

PMID:
20400760
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk